Bristol-Myers Squibb buy tamam
Start price
03.01.19
/
50%
€43.41
Target price
04.11.21
€72.00
Performance (%)
17.75%
End price
05.11.21
€51.12
Summary
This prediction ended on 05.11.21 with a price of €51.12. The prediction had a final performance of 17.75%. A total of €4.86 was paid as dividends for this prediction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | -0.982% | -0.982% | -29.102% | -16.941% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by tamam for this prediction
In the thread Bristol-Myers Squibb diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 03.01.2019 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 59.93$ zu.
Kursziel geändert auf 62,0
Kursziel geändert auf 72,0
In the thread Trading Bristol-Myers Squibb
Die von tamam gewählte maximale Laufzeit wurde überschritten